JOCELYN SEGOVIA: Open Payments
NPI 1215991997 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,097 in 56 payments from 12 companies in 2025. Trend: 2023 $1,563 · 2024 $1,228 · 2025 $1,097
Food & beverage: $1,097
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 12 | $253 |
| PFIZER INC. | 10 | $210 |
| ABBVIE INC. | 10 | $154 |
| Forte Bio-Pharma LLC | 7 | $143 |
| Lundbeck LLC | 5 | $121 |
| Axsome Therapeutics, Inc. | 3 | $52 |
| SCILEX PHARMACEUTICALS INC. | 2 | $37 |
| Impel Pharmaceuticals LLC | 2 | $33 |
| PROTEGA PHARMACEUTIALS INC | 2 | $32 |
| Averitas Pharma Inc. | 1 | $25 |
Products named: RELISTOR, NURTEC ODT, VYEPTI, PROLATE, QULIPTA, Symbravo, UBRELVY, BOTOX.
Industry payments across NV — which companies pay providers there.
